Comment Comment by streptomycin Its own bill for landmark trials of a four-drug combination treatment for drug-resistant tuberculosis came to €34m (£29m).Okay, how does that compare to what pharma companies spend? The article cites some unrelated numbers, doesn't actually compare.A quick Google search says:The average cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively.So... not really that different? What's the big deal here? parent streptomycin 2 years ago
Okay, how does that compare to what pharma companies spend? The article cites some unrelated numbers, doesn't actually compare.
A quick Google search says:
The average cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively.
So... not really that different? What's the big deal here?